Welcome
FDA places new warning on Avandia label
February 16th, 2011
A new warning about the risk of heart attack or other cardiovascular side effects has been added to the label of the diabetes drug Avandia. The Food and Drug Administration announced in September 2010 that if would severely restrict the…more »
FDA decides to severely restrict diabetes drug Avandia
January 5th, 2011
In September 2010, a Food and Drug Administration panel voted to severely restrict sales of the diabetes drug Avandia. The agency announced that patients in the U.S. will only be allowed to use the drug if treatment with other diabetes…more »
FDA announces new restrictions on Avandia prescriptions
December 22nd, 2010
In September 2010, the Food and Drug Administration announced new restrictions on the use of Avandia that may significantly limit the number of patients eligible to take the drug. The agency issued the new restrictions in response to data…more »
Study finds Avandia side effects risk equal to Actos
October 11th, 2010
A August 2010 study published in the journal Circulation shows that Actos may be no safer at treating diabetes symptoms then Avandia. Actos has been perceived as safer ever since recent reports about the side effects of Avandia were issued.…more »
Avandia Maker Ordered to Stop Enrolling Patients in Clinical Trials
September 5th, 2010
In July 2010, month the Food and Drug Administration ordered the maker of the diabetes drug Avandia to stop enrolling patients in a controversial clinical trial, saying it needs time to study new evidence of the drug’s risks. An FDA…more »
FDA Advisory Committee Member a Paid Speaker for GlaxoSmithKline
August 29th, 2010
According to an article in the Wall Street Journal, one of the 33 members of a Food and Drug Administration panel to review Avandia was a paid speaker for the diabetes drug’s manufacturer, GlaxoSmithKline. Endocrinologist David Capuzzi has been paid a total…more »
Avandia prescription numbers fall after side effects warnings
August 23rd, 2010
In the wake of several studies of the health risks associated with the diabetes drug Avandia, many experts now say there are no reasons to continue prescribing Avandia when safer and equally effective alternatives are available.
more »
FDA Advisory Committee Votes to Restrict Avandia
August 17th, 2010
In July 2010, a Food and Drug Administration advisory panel voted to recommend that the agency should withdraw or severely restrict the sale of Avandia due to its potential to increase the risk of heart attacks.
more »
Avandia watchdog appointed to FDA position
October 18th, 2009
The Food and Drug Administration has appointed consumer advocate Peter Lurie as a policy advisor, signaling a shift in the agency’s regulatory approach. Prior to coming to the FDA, Lurie worked with the consumer’s group Public Citizen, where he helped…more »
Avandia users face increased heart failure, death risk, study finds
August 25th, 2009
A study by Canadian researches has revealed that patients taking the type-2 diabetes drug Avandia may be at an increased risk of heart failure or death compared with those taking another kind of diabetes drug. Scientists with the study say…more »